S&P 500

5.308,15

1,17%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

CADX

(MM) (CADX)

(MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:CADX

1 2 3 4 5 6 7 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
14/04/2014	11:47	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:CADX	(MM)
01/04/2014	18:12	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:CADX	(MM)
24/03/2014	12:29	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:CADX	(MM)
21/03/2014	20:43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CADX	(MM)
19/03/2014	17:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CADX	(MM)
19/03/2014	17:11	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:CADX	(MM)
19/03/2014	17:07	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:CADX	(MM)
19/03/2014	10:45	Edgar (US Regulatory)	(25-NSE)	NASDAQ:CADX	(MM)
19/03/2014	10:12	Business Wire	Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.	NASDAQ:CADX	(MM)
19/03/2014	07:42	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CADX	(MM)
19/03/2014	07:23	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CADX	(MM)
13/03/2014	19:00	Zacks	FDA Approves Mallinckrodt's Xartemis XR - Analyst Blog	NASDAQ:CADX	(MM)
13/03/2014	17:11	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:CADX	(MM)
10/03/2014	16:16	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CADX	(MM)
06/03/2014	13:50	PR Newswire (US)	Stock Price Updates, Appointment, and Financial Results - Analyst Notes on Regeneron, DENTSPLY, AMAG, Cadence, and ArthroCare	NASDAQ:CADX	(MM)
28/02/2014	18:17	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:CADX	(MM)
28/02/2014	18:00	PR Newswire (US)	Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results	NASDAQ:CADX	(MM)
19/02/2014	17:48	PR Newswire (US)	Lifshitz & Miller Law Firm Announces Investigation of Cadence Pharmaceuticals, Inc., Chindex International, Inc., LCA-Vision,...	NASDAQ:CADX	(MM)
19/02/2014	13:35	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:CADX	(MM)
19/02/2014	08:02	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:CADX	(MM)
17/02/2014	15:54	Business Wire	SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. in Connecti...	NASDAQ:CADX	(MM)
14/02/2014	18:50	PR Newswire (US)	CADENCE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout	NASDAQ:CADX	(MM)
14/02/2014	16:06	Business Wire	SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc.	NASDAQ:CADX	(MM)
14/02/2014	14:30	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:CADX	(MM)
14/02/2014	12:21	Edgar (US Regulatory)	Schedule 13g	NASDAQ:CADX	(MM)
13/02/2014	20:33	Business Wire	INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. & Its Board of Directors in Con...	NASDAQ:CADX	(MM)
13/02/2014	18:24	Business Wire	CADENCE INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating Cadence Pharmaceuticals, Inc. (CADX) in Relation to the Propose...	NASDAQ:CADX	(MM)
12/02/2014	19:07	PR Newswire (US)	SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. - CADX	NASDAQ:CADX	(MM)
12/02/2014	14:26	Business Wire	Cadence Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate Sale to Mallinc...	NASDAQ:CADX	(MM)
12/02/2014	13:31	PR Newswire (US)	Ryan & Maniskas, LLP Announces Investigation of Cadence Pharmaceuticals Inc.	NASDAQ:CADX	(MM)